FBLG - CIK 0001958777
FibroBiologics, Inc. has filed 209 documents with the SEC between 2023 and 2026. The most frequent type is major company event (38 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| D | - | 2025-12-03 | - |
| Major company event | 8-K | 2025-11-25 | 2025-11-24 |
| Prospectus supplement | 424B5 | 2025-11-25 | - |
| Prospectus supplement | 424B5 | 2025-11-20 | - |
| Major company event | 8-K | 2025-11-19 | 2025-11-18 |
| Quarterly report | 10-Q | 2025-10-31 | 2025-09-30 |
| Major company event | 8-K | 2025-08-08 | 2025-08-04 |
| Quarterly report | 10-Q | 2025-07-31 | 2025-06-30 |
| Major company event (amended) | 8-K/A | 2025-07-18 | 2024-12-20 |
| Major company event | 8-K | 2025-07-18 | 2025-06-20 |
| SCHEDULE 13G/A | - | 2025-07-17 | - |
| Major company event | 8-K | 2025-07-03 | 2025-07-01 |
| Major company event | 8-K | 2025-06-16 | 2025-06-16 |
| Major company event | 8-K | 2025-06-13 | 2025-06-12 |
| Insider trade | 4 | 2025-06-12 | 2025-06-12 |
| Insider trade | 4 | 2025-06-12 | 2025-06-12 |
| Insider trade | 4 | 2025-06-12 | 2025-06-12 |
| Insider trade | 4 | 2025-06-12 | 2025-06-12 |
| Insider trade | 4 | 2025-06-12 | 2025-06-12 |
| Insider trade | 4 | 2025-06-10 | 2025-06-09 |
| New insider ownership | 3 | 2025-06-10 | 2025-06-09 |
| Major company event | 8-K | 2025-06-09 | 2025-06-09 |
| SCHEDULE 13G | - | 2025-06-06 | - |
| Insider trade | 4 | 2025-05-27 | 2025-05-27 |
| Quarterly report | 10-Q | 2025-05-14 | 2025-03-31 |
| Major company event | 8-K | 2025-05-05 | 2025-05-02 |
| Annual report to shareholders | ARS | 2025-04-23 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-23 | - |
| Proxy statement | DEF 14A | 2025-04-23 | 2024-12-31 |
| PRE 14A | - | 2025-04-11 | 2024-12-31 |
| Annual report | 10-K | 2025-03-31 | 2024-12-31 |
| Insider trade | 4 | 2025-03-28 | 2025-03-26 |
| Insider trade | 4 | 2025-03-28 | 2025-03-26 |
| Insider trade | 4 | 2025-03-28 | 2025-03-26 |
| SCHEDULE 13G | - | 2025-02-12 | - |
| EFFECT | - | 2025-02-10 | - |
| Major company event | 8-K | 2025-02-07 | 2025-01-07 |
| Company correspondence | CORRESP | 2025-02-06 | - |
| SEC correspondence | UPLOAD | 2025-02-06 | - |
| Securities registration | S-3 | 2025-02-03 | - |
| SCHEDULE 13G/A | - | 2025-01-30 | - |
| SCHEDULE 13G | - | 2025-01-29 | - |
| Major company event | 8-K | 2025-01-24 | 2025-01-23 |
| EFFECT | - | 2025-01-21 | - |
| POS AM | - | 2025-01-17 | - |
| EFFECT | - | 2025-01-14 | - |
| 424B4 | - | 2025-01-14 | - |
| Company correspondence | CORRESP | 2025-01-10 | - |
| S-1/A | - | 2025-01-10 | - |
| SEC correspondence | UPLOAD | 2025-01-06 | - |